Pruritus (Juckreiz) bei Psoriasis
- PSORITUS (CAIN457ADE03)
- Exploratory study on kinetics of pruritus intensity and lesional remission in psoriasis patients treated with subcutenous secukinumab (300 mg) during a 16 week run-in-phase followed by a 16 week randomized withdrawal period in a double-blind, placebo-controlled design
- Studie beendet
Letzte Aktualisierung:
01. Juli 2024
Aktualisierte Beiträge:
- Allgemeines
- Nicht-interventionelle Studien
- Registertätigkeiten
- Wissenschaftliche Vorträge